Posted in | News | Mining Business

Uranium Hunter and Minas Core Mining Sign Stock Purchase Agreement

Uranium Hunter Corporation ("The Company") is pleased to announce the execution of the Stock Purchase Agreement between the Company and Minas Core Mining Inc., a Nevada Corporation and owner operator of the Rio Petro Diamond Project in Brazil.

Under the terms of the Agreement, the Company will receive 80% (eighty percent) or 40,000,000 (Forty Million) authorized shares of Minas Core Mining Inc. for the aggregate consideration of $3,200,000 (Three Million Two Hundred Thousand Dollars) payable by 3,200,000,000 (Three Billion Two Hundred Million) shares of the Company's common stock with a one-year restriction as may be permitted under Rule 144 under the Securities Act of 1933.

In addition, the Company will contribute $6,000,000 (Six Million Dollars) over a 30 (Thirty) month period towards the work program, operational costs, equipment and further development of the Rio Petro Diamond Project in Brazil through Minas Core Mining Inc. and/or its subsidiaries.

Reno J. Calabrigo, President, stated, "We are working closely with Minas Core Mining and its Management Team to launch an aggressive development and work program for the upcoming season." Mr. Calabrigo further stated, "We will be providing in depth information in the near future on the Rio Petro Diamond Project including historical references, open pit probing surveys, previous work programs and their findings, as well as plans for further development, modernization and expansion of the project."

Source:

Uranium Hunter Corporation

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.